{
    "clinical_study": {
        "@rank": "114533", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Investigate the efficacy and safety of colchicine therapy in improving hepatic function\n      and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis."
        }, 
        "brief_title": "Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis", 
        "condition": [
            "Cirrhosis", 
            "Liver Cirrhosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Patients receive colchicine orally twice daily for 24 months.  After the\n      first month, the dose of colchicine will increase and remain at that dose for the duration\n      of study.\n\n      Patients are evaluated every 6 months during study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Advanced hepatic fibrosis or cirrhosis in children\n\n          -  Not pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "15", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004368", 
            "org_study_id": "199/11947", 
            "secondary_id": "CHD-1089"
        }, 
        "intervention": {
            "intervention_name": "colchicine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Colchicine"
        }, 
        "keyword": [
            "hepatic cirrhosis", 
            "gastrointestinal disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Children's Hospital Colorado", 
            "last_name": "Ronald J. Sokol", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004368"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital Colorado", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "May 1990", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2003"
    }, 
    "geocoordinates": {}
}